References
- Gelband H, Jha P, Sankaranarayanan R, Horton S (eds). Cancer: disease control priorities (Volume 3): third Edition. 2015 Washington (DC). The World Bank Publications. PubMed | Google Scholar
- Tshomo U, Franceschi S, Tshokey T, Tobgay T, Baussano I, Tenet V et al. Evaluation of cyto-logy versus human papillomavirus-based cervical cancer screening algorithms in Bhutan. On-cotarget. 2017; 8(42): 72438-72446. PubMed | Google Scholar
- Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine. 2006; 24(Suppl3):S3/71-7. PubMed | Google Scholar
- Nour NM. Cervical cancer: a preventable death. Rev Obstet Gynecol. 2009; 2(4): 240-4. PubMed | Google Scholar
- Marlow LA, Wardle J, Waller J. Understanding cervical screening non-attendance among ethnic minority women in England. Br J Cancer. 2015; 113(5): 833-9. PubMed | Google Scholar
- Enerly E, Bonde J, Schee K, Pedersen H, Lönnberg S, Nygĺrd M. Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme. PLoS One. 2016; 11(4): e0151978. PubMed | Google Scholar
- Belinson JL, Du H, Yang B, Wu R, Belinson SE, Qu X et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer. 2012; 130(8): 1855-60. PubMed | Google Scholar
- ICO Information Centre on HPV and Cancer (HPV Information
Centre). Human
Papillomavirus and Related Diseases Report. 2nd July 2017. Accessed on
Mar 2018.
- Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJF et al. Human papillo-mavirus infection in women with and without cervical cancer in Ibadan Nigeria. Infect Agent Cancer. 2010; 5: 24. PubMed | Google Scholar
- Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies. Int J Cancer. 2012; 130(9): 2111-2117. PubMed | Google Scholar
- Nweke IG, Banjo AAF, Abdulkareem FB, Nwadike VU. Prevalence of Human Papilloma Virus DNA in HIV Positive Women in Lagos University Teaching Hospital (LUTH) Lagos Ni-geria. BMRJ. 2013; 3(3): 400-413. Google Scholar
- Manga MM, Fowotade A, Abdullahi YM, El-Nafaty AU, Adamu DB, Pindiga HU et al. Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria. Infect Agent Cancer. 2015; 10(1): 39. PubMed | Google Scholar
- Auwal IK, Aminu M, Atanda AT, Tukur J, Sarkinfada F. Prevalence and Risk Factors of High Risk Human Papillomavirus Infections among Women Attending Gynaecology Clinics in Kano Northern Nigeria. Bayero J Pure Appl Sci. 2014; 6(1): 67-71. Google Scholar
- Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W et al. Comparison of the perfor-mance of different HPV genotyping methods for detecting genital HPV types. J Med Virol. 2008; 80(7): 1264-74. PubMed | Google Scholar
- Tsiodras S, Georgoulakis J, Chranioti A, Voulgaris Z,
Psyrri A, Tsivilika A et al. Hybrid capture vs PCR screening of cervical human
papilloma virus infections: cytological and histological associations in 1270
women. BMC Cancer. 2010; 10: 53. PubMed | Google Scholar
- Modibbo F, Iregbu KC, Okuma J, Leeman A, Kasius A, de
Koning M et al. Randomized trial evaluating self-sampling for HPV DNA based
tests for cervical cancer screening in Nigeria. Infect Agent Cancer. 2017;
12: 11. PubMed | Google
Scholar
- Rahman M, Sasagawa T, Yamada R, Kingoro A, Ichimura H, Makinoda S. High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of Kenyan women in-fected with human immunodeficiency virus. J Med Virol. 2011; 83(11): 1988-96. PubMed | Google Scholar
- Balanda M, Quiero A, Vergara N, Espinoza G, Martín HS, Rojas G et al. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015. Med Microbiol Immunol. 2016; 205(6): 585-594. PubMed | Google Scholar
- Baloch Z, Li Y, Yuan T, Feng Y, Liu Y, Tai W et al. Epidemiologic characterization of hu-man papillomavirus (HPV) infection in various regions of Yunnan Province of China. BMC In-fect Dis. 2016; 16: 228. PubMed | Google Scholar
- Orozco-Colín A, Carrillo-García A, Méndez-Tenorio A,
Ponce-de-León S, Mohar A, Maldonado-Rodríguez R et al. Geographical variation
in human papillomavirus prevalence in Mexi-can women with normal cytology.
Int J Infect Dis. 2010; 14(12): e1082-7. PubMed | Google
Scholar
- De Alba I, Anton-Culver H, Hubbell FA, Ziogas A, Hess JR, Bracho A et al. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epi-demiol Biomarkers Prev. 2008; 17(8): 2163-8. PubMed | Google Scholar
- Cw N, Boga H, Aw M, Wanzala P, Jn M. Factors affecting
uptake of Cervical Cancer Early Detection measures among women in Thika Kenya.
Health Care For Women International. 2012; 33(7): 595-613. Google
Scholar
- Karwalajtys T, Howard M, Sellors JW, Kaczorowski J. Vaginal self sampling versus physi-cian cervical sampling for HPV among younger and older women. Sex Transm Infect. 2006; 82(4): 337-9. PubMed | Google Scholar
- Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical sam-ples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol. 2009; 33(6): 446-50. PubMed | Google Scholar
- Seo SS, Song YS, Kim JW, Park NH, Kang SB, Lee HP. Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleo-tide microarray. Gynecol Oncol. 2006; 102(1): 67-73. PubMed | Google Scholar
- Safaeian M, Kiddugavu M, Gravitt PE, Ssekasanvu J, Murokora
D, Sklar M et al. Comparability of self-collected vaginal swabs and physician-collected
cervical swabs for detection of human papillomavirus infections in Rakai Uganda.
Sex Transm Dis. 2007; 34(7): 429-36. PubMed | Google
Scholar